Search

everythinglearnresearchcommunity

for

Search:↓

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Entospletinib effectively prevents eye and skin GVHD in mice.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

JAK inhibitors show promise in treating difficult skin diseases.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Tofacitinib may help treat hair loss in children with alopecia areata.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Nicastrin deficiency may cause skin cell damage and pigmentation disorders in humans, similar to effects seen in fish.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.